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Summary
Background: The importance of risk stratiﬁcation for sudden cardiac death (SCD) after sep-
tal myectomy for hypertrophic obstructive cardiomyopathy (HOCM) has not been emphasized
previously.
Methods and results: We report 2 patients with SCD or ventricular tachycardia (VT) afterRisk factors;
Cardioverter-
deﬁbrillator;
HOCM;
septal myectomy for HOCM in whom risk factors for SCD were identiﬁed following surgical
myectomy. One received an implantable cardioverter-deﬁbrillator (ICD), which subsequently
provided appropriate discharges for VT. The other delayed ICD implantation and suffered SCD.
Conclusion: These cases emphasize the importance of risk stratiﬁcation for SCD after septal
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cHeart disease;
Myectomy
myectomy for HOCM.
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1. Introduction
The prevention of sudden cardiac death (SCD) in patients
with hypertrophic cardiomyopathy (HCM) is central to man-
agement of the disease [1]. In patients with hypertrophic
obstructive cardiomyopathy (HOCM) and symptoms refrac-
tory to medical therapy, septal myectomy reduces resting
and dynamic left ventricular outﬂow tract (LVOT) gradients
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nd improves New York Heart Association functional status
n the majority of patients [2—6]. While the incidence of
CD after septal myectomy was reported to be low at one
enter [4], the surgery does not eliminate the risk of SCD.
erein, we report 2 patients, in whom risk factors for SCD
ere identiﬁed following extensive surgical myectomy.
.1. Case studiesase 1. A 41-year-old man had exertional dyspnea, chest
ightness, palpitations, and lightheadedness. He had had
episode of syncope 7 years previously. There was no
amily history of SCD. Echocardiogram showed septal thick-
Published by Elsevier Ireland Ltd. All rights reserved.
e66 R.D. Rothman et al.
F d cin
b gical
m
n
a
t
h
o
P
t
u
s
s
3
a
m
s
t
l
s
p
(
m
a
r
c
t
o
t
p
r
L
e
w
a
H
ﬁ
t
o
l
r
m
s
r
d
v
v
v
o
t
m
myectomy, and days before a scheduled appointment with
an arrhythmia specialist, the patient collapsed while walk-
ing. Resuscitation was unsuccessful.
Figure 2 Histopathology of the myocardium from amyectomy
specimen (Masson-trichrome stain× 100). There is myoﬁber dis-igure 1 End-diastolic left ventricular short axis white bloo
asal level, showing thin myocardium (8mm, arrows) at the sur
yocardium remote from the surgical site (32mm, arrow).
ess 28mm and peak LVOT gradient 143mmHg. Coronary
rteriography was normal. Because of symptoms refrac-
ory to the combination of metoprolol and disopyramide,
e underwent extensive septal myectomy, with resection
f myocardial tissue as deep in the ventricle as possible.
ostoperatively, there was resolution of symptoms and of
he LVOT gradient. Holter monitoring showed rare ventric-
lar premature beats. Cardiac magnetic resonance (CMR)
howed residual septal thickness 8mm at the myectomy
ite (Fig. 1A) and maximal left ventricular wall thickness
2mm remote from the myectomy site (Fig. 1B). After the
dministration of gadolinium, there was delayed enhance-
ent, indicative of ﬁbrosis. On a treadmill exercise test,
ystolic blood pressure increased from 132mmHg at rest
o 138mmHg at peak exercise. Because of marked residual
eft ventricular hypertrophy at a nonsurgical site and the
ubnormal blood pressure augmentation with exercise, the
atient underwent implantable cardioverter-deﬁbrillator
ICD) implantation 6 months after septal myectomy. Four
onths after ICD implantation, the patient experienced
n episode of lightheadedness. Interrogation of the ICD
evealed two appropriate discharges for ventricular tachy-
ardia (VT) at rates of 226 and 218 beats/min, respectively.
Case 2. A 45-year-old man had dyspnea on minimal exer-
ion, chest pain, and fatigue. He had no history of syncope
r presyncope. There was no family history of SCD. Despite
reatment with an optimal dosage of atenolol, his symptoms
rogressed. Exercise echocardiography revealed asymmet-
ic septal hypertrophy with maximal wall thickness 34mm.
VOT gradient was 10mmHg at rest and 111mmHg with
xercise. Coronary arteriography was normal. He under-
ent septal myectomy, with the resection carried as far
s possible towards the base of the papillary muscles.
istopathology revealed myocyte hypertrophy, moderate
ber disarray, and multiple ﬁbrous scars (Fig. 2). Postopera-
ive treadmill exercise testing showed normal augmentation
f blood pressure and suppression of baseline ventricu-
ar ectopy, including couplets, with exercise. CMR showed
esidual wall thickness 11mm at the myectomy site and
a
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ae magnetic resonance imaging after septal myectomy. (A) At
site. (B) At mid-ventricular level, showing markedly thickened
aximum wall thickness 30mm remote from the myectomy
ite. Images obtained after administration of gadolinium
evealed moderately extensive mid-myocardial areas of
elayed enhancement affecting the regions of the inter-
entricular septum opposite the anterior and inferior right
entricular insertion points, extending through most of the
entricle from the basal to the apical region. On the basis
f these CMR ﬁndings, we recommended ICD placement;
he patient was initially reluctant to follow this recom-
endation, resulting in a delay. Five months after septalrray with haphazard and perpendicularly oriented myocytes
red). Collagenous interstitium (blue) indicative of ﬁbrosis is
rominent. (For interpretation of the references to color in this
gure legend, the reader is referred to the web version of the
rticle.)
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2. Discussion
Established risk factors for SCD in HCM include unexplained
syncope, family history of SCD, marked left ventricular
hypertrophy (≥ 30mm), VT, and a decrease or subnormal
(< 20mmHg) increase in systolic blood pressure on exercise
testing [1,7]. The association between marked hypertro-
phy and SCD was derived from echocardiographic studies;
therefore, it is not known with certainty that wall thickness
measurements obtained by CMR have the same prognostic
signiﬁcance. More recently, investigations utilizing delayed
gadolinium enhancement on magnetic resonance imaging to
quantify the extent of myocardial ﬁbrosis have suggested an
association of this parameter with SCD [8—11]. While these
studies are suggestive, the extent of delayed enhancement
has not been established as a major risk factor.
Similarly, while some studies have suggested that the
presence of LVOT obstruction is an independent risk factor
for SCD, obstruction has not been included in the stan-
dard recommendations for risk stratiﬁcation [1]. The effect
of septal myectomy on the risk of SCD has been assessed
in retrospective studies. Woo et al. studied 338 consecu-
tive patients who underwent myectomy [12]. Over 7.7± 5.7
years of follow-up, there were 43 cardiac deaths, of which 13
were sudden. Ommen et al. compared outcomes in 289 con-
secutive patients who underwent isolated septal myectomy
with those in 228 nonoperated patients with LVOT obstruc-
tion [4]. In the surgical group, there were 2 operative and
7 late cardiac deaths, of which 5 were sudden; appropriate
ICD discharge was counted as SCD. Survival free from SCD
was 99% at 10 years after septal myectomy, compared to
89% for nonoperated obstructed patients. Since SCD was not
abolished by myectomy, the authors suggested that ‘‘risk
stratiﬁcation is still required for patients undergoing this
procedure.’’
3. Conclusion
The 2 case studies we present emphasize the need for risk
stratiﬁcation for SCD in patients undergoing septal myec-
tomy, with ICD implantation, if indicated, before or after
surgery. In the absence of data indicating that SCD risk fac-
tors after myectomy differ from those in the general HCM
cohort, it seems prudent to apply current recommendations
to risk stratiﬁcation in the postoperative patient.
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